Table 4 Characteristics of radical radiotherapy in NSCLC and SCLC patients
From: Pattern of use of radiotherapy for lung cancer: a descriptive study
Radical radiotherapy in NSCLC | |||||||||
|---|---|---|---|---|---|---|---|---|---|
Histology (%) | Stage (%) | RT dose (%) | RT delay (%) | Associated CT (%) | |||||
SCC | 48.1 | I | 6.2 | <60 Gy | 26 | <30 days | 49.7 | No | 20.6 |
ADC | 21.7 | II | 12.1 | ≥60 Gy | 74 | ≥30 days | 50.3 | Seq | 32.6 |
LCUC | 17.5 | III | 65.3 | Conc | 41.7 | ||||
Others | 12.7 | IV | 16.4 | Both | 5.1 | ||||
Radical radiotherapy in SCLC | |||||||||
RT dose (%) | RT delay (%) | Associated CT (%) | |||||||
<45 Gy | 3 | <30 days | 33 | No | 0 | ||||
≥45 Gy | 97 | ≥30 days | 67 | Sequential | 26 | ||||
Concomitant | 63 | ||||||||
Both | 11 | ||||||||